Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 5/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.65 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.65 |
| ▸ | MAPT | P10636 | 7/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.50 |
| ▸ | LMNA | P02545 | 4/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.44 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | PDE4A | P27815 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29645273 | 0.89 | MAPT (0.68) | HPGDHSD17B10ALOX15MAPTNPSR1 | |
| SCHEMBL3830500 | 0.89 | HPGD (0.67) | HPGDHSD17B10ALOX15MAPTNPSR1 | |
| SCHEMBL77201 | 0.89 | MAPT (0.68) | HPGDHSD17B10ALOX15MAPTNPSR1 | |
| SCHEMBL28320193 | 0.88 | MAPT (0.67) | HPGDHSD17B10ALOX15MAPTNPSR1 | |
| Phenyl Salicylate SCHEMBL6429855 | 0.86 | HSD17B10 (0.73) | HPGDHSD17B10ALOX15MAPTNPSR1 | |
| SCHEMBL7614991 | 0.85 | HPGD (0.88) | HPGDHSD17B10ALOX15MAPTNPSR1 | |
| SCHEMBL8205574 | 0.84 | TDP1 (0.67) | HPGDHSD17B10ALOX15MAPTNPSR1 | |
| Phenol SCHEMBL28229407 | 0.84 | HSD17B10 (0.64) | HPGDHSD17B10ALOX15MAPTNPSR1 | |
| SCHEMBL698506 | 0.82 | HPGD (0.58) | HPGDHSD17B10ALOX15MAPTNPSR1 | |
| SCHEMBL9431524 | 0.82 | MAPT (0.60) | HPGDHSD17B10ALOX15MAPTNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 562 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8168227-B2 | Modified powder and cosmetic composition using the same | SHISEIDO CO., LTD. (JP) | 2012-05-01 | — | — | US | claimed |
| US-20100047185-A1 | ACTVIE SUBSTANCE COMBINATION | ISDIN S.A. (ES) | 2010-02-25 | — | — | US | claimed |
| WO-2008083975-A1 | LIGHT-STABILIZED COMPOSITION | ISDIN S.A. (ES) | 2008-07-17 | — | — | WO | claimed |
| WO-2008083974-A1 | ACTIVE SUBSTANCE COMBINATION | ISDIN S.A. (ES) | 2008-07-17 | — | — | WO | claimed |
| WO-2008067928-A1 | UV ABSORBING COMPOSITIONS CONTAINING A PYRROLYLTRIAZINE | ISDIN S.A. (ES) | 2008-06-12 | — | — | WO | claimed |
| US-20070253989-A1 | Modified Powder and Cosmetic Composition Using the Same | SHISEIDO CO., LTD. (JP) | 2007-11-01 | — | — | US | claimed |
| EP-4372042-A2 | RESIN ADDITIVE COMPOSITION, THERMOPLASTIC RESIN COMPOSITION, AND MOLDED ARTICLE THEREOF | Adeka Corporation (JP) | 2024-05-22 | — | — | EP | disclosed |
| EP-4358933-A1 | COPOLYMER THICKENING COMPOSITION COMPRISING AT LEAST ONE OIL AND AT LEAST ONE POLY(ITACONATE) FOR THICKENING POLAR OR APOLAR OILS | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) | 2024-05-01 | — | — | EP | disclosed |
| EP-4358932-A1 | THICKENING COMPOSITION FOR THICKENING POLAR OR NON-POLAR OILS | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) | 2024-05-01 | — | — | EP | disclosed |
| EP-4349418-A2 | TOPICALLY ADMINISTRABLE HELICHRYSUM STOECHAS PLANT DEDIFFERENTIATED CELL LYSATE (LY) FOR REMOVING OR REDUCING SKIN INFLAMMATION | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) | 2024-04-10 | — | — | EP | disclosed |
| EP-4106784-B1 | TOPICALLY ADMINISTRABLE LYSATE (LY) OF DEDIFFERENTIATED CELLS OF THE PLANT HELICHRYSUM STOECHAS FOR ELIMINATING OR REDUCING INFLAMMATION OF THE SKIN | SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2024-04-03 | — | — | EP | disclosed |
| US-20240099955-A1 | SKINCARE COMPOSITIONS AND METHODS OF USE THEREOF | HTL BIOTECHNOLOGY INNOVATION INC. | 2024-03-28 | — | — | US | disclosed |
| EP-4331686-A2 | TEMPERATURE-STABLE ALKANE AND ESTER COMPOSITIONS, THEIR USE AS EMOLLIENT AGENTS, AND EMULSIONS COMPRISING THEM | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) | 2024-03-06 | — | — | EP | disclosed |
| EP-0697212-A2 | Deodorant cosmetic composition superior in resistance to discoloration and dispersion | SHINAGAWA FUEL CO., LTD. (JP) | 1996-02-21 | — | — | EP | disclosed |
| EP-0487404-B1 | External dermatological composition | HAYASHIBARA BIOCHEM LAB (JP) | 1995-10-11 | — | — | EP | disclosed |
| US-5427771-A | Stable dispersion in cosmetically acceptable vehicle with adjuvants | L'OREAL (FR) | 1995-06-27 | — | — | US | disclosed |
| WO-1995009895-A1 | ULTRAVIOLET SHIELDING COMPOSITE FINE PARTICLES, METHOD FOR PRODUCING THE SAME, AND COSMETICS | KAO CORPORATION (JP) | 1995-04-13 | — | — | WO | disclosed |
| EP-0487404-A1 | External dermatological composition | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 1992-05-27 | — | — | EP | disclosed |
| US-5000937-A | Transparent cosmetic composition that reflects infrared radiation and its use for protecting the human epidermis against infrared radiation | L'OREAL (FR) | 1991-03-19 | — | — | US | disclosed |
| EP-0211183-A2 | Use of ubidecarenone(ubiquinone-10) as an antichromatotic agent | Eisai Co., Ltd. (JP) | 1987-02-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100047185-A1 | ACTVIE SUBSTANCE COMBINATION | UGT2B17, TACR2, UGT1A1 | HPGD 601/4885HSD17B10 396/4885ALOX15 714/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.